Annual report

Period2023-01-01 → 2023-12-31

Filed2024-03-29

StandardIFRS

ConsolidatedYes

Data checks18 of 19 passed

Key figures · 144

Metric	Value	Period	Scope	Source row
Revenue	¥40m	2023-01-01 → 2023-12-31	Cons.	Revenue IFRS (5-year summary)
Revenue	¥8m	2022-01-01 → 2022-12-31	Cons.	Revenue IFRS (5-year summary)
Revenue	¥38m	2020-01-01 → 2020-12-31^d	Cons.	Revenue IFRS (5-year summary)
Operating income	−¥1.5bn	2023-01-01 → 2023-12-31	Cons.	Operating profit loss IFRS
Operating income	−¥2.0bn	2022-01-01 → 2022-12-31	Cons.	Operating profit loss IFRS
Profit before tax	−¥1.5bn	2023-01-01 → 2023-12-31	Cons.	Profit loss before tax IFRS
Profit before tax	−¥2.0bn	2022-01-01 → 2022-12-31	Cons.	Profit loss before tax IFRS
Profit before tax	−¥2.6bn	2021-01-01 → 2021-12-31^d	Cons.	Profit loss before tax IFRS (5-year summary)
Profit before tax	−¥2.4bn	2020-01-01 → 2020-12-31^d	Cons.	Profit loss before tax IFRS (5-year summary)
Profit before tax	−¥3.1bn	2019-01-01 → 2019-12-31^d	Cons.	Profit loss before tax IFRS (5-year summary)
Net income (owners)	−¥1.5bn	2023-01-01 → 2023-12-31	Cons.	Profit loss attributable to owners of parent IFRS
Net income (owners)	−¥2.0bn	2022-01-01 → 2022-12-31	Cons.	Profit loss attributable to owners of parent IFRS
Net income (owners)	−¥2.6bn	2021-01-01 → 2021-12-31^d	Cons.	Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)	−¥2.4bn	2020-01-01 → 2020-12-31^d	Cons.	Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)	−¥3.1bn	2019-01-01 → 2019-12-31^d	Cons.	Profit loss attributable to owners of parent IFRS (5-year summary)
Net income	−¥1.5bn	2023-01-01 → 2023-12-31	Cons.	Profit loss IFRS
Net income	−¥2.0bn	2022-01-01 → 2022-12-31	Cons.	Profit loss IFRS
Total assets	¥3.0bn	at 2023-12-31	Cons.	Assets IFRS
Total assets	¥4.4bn	at 2022-12-31	Cons.	Assets IFRS
Total assets	¥4.8bn	at 2021-12-31^d	Cons.	Total assets IFRS (5-year summary)
Total assets	¥6.7bn	at 2020-12-31^d	Cons.	Total assets IFRS (5-year summary)
Total assets	¥8.7bn	at 2019-12-31^d	Cons.	Total assets IFRS (5-year summary)
Total liabilities	¥370m	at 2023-12-31	Cons.	Liabilities IFRS
Total liabilities	¥470m	at 2022-12-31	Cons.	Liabilities IFRS
Net assets / equity	¥2.6bn	at 2023-12-31	Cons.	Equity IFRS
Net assets / equity	¥3.9bn	at 2022-12-31	Cons.	Equity IFRS
Net assets / equity	¥4.2bn	at 2021-12-31^d	Cons.	Equity IFRS
Equity (owners)	¥2.6bn	at 2023-12-31	Cons.	Equity attributable to owners of parent IFRS
Equity (owners)	¥3.9bn	at 2022-12-31	Cons.	Equity attributable to owners of parent IFRS
Equity (owners)	¥4.2bn	at 2021-12-31^d	Cons.	Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)	¥6.0bn	at 2020-12-31^d	Cons.	Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)	¥8.1bn	at 2019-12-31^d	Cons.	Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents	¥2.8bn	at 2023-12-31	Cons.	Cash and cash equivalents IFRS
Cash & equivalents	¥4.0bn	at 2022-12-31	Cons.	Cash and cash equivalents IFRS
Cash & equivalents	¥4.0bn	at 2021-12-31^d	Cons.	Cash and cash equivalents IFRS
Cash & equivalents	¥2.5bn	at 2020-12-31^d	Cons.	Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents	¥4.2bn	at 2019-12-31^d	Cons.	Cash and cash equivalents IFRS (5-year summary)
Operating cash flow	−¥1.3bn	2023-01-01 → 2023-12-31	Cons.	Net cash provided by used in operating activities IFRS
Operating cash flow	−¥2.1bn	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in operating activities IFRS
Operating cash flow	−¥2.5bn	2021-01-01 → 2021-12-31^d	Cons.	Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow	−¥2.2bn	2020-01-01 → 2020-12-31^d	Cons.	Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow	−¥3.4bn	2019-01-01 → 2019-12-31^d	Cons.	Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow	−¥45m	2023-01-01 → 2023-12-31	Cons.	Net cash provided by used in investing activities IFRS
Investing cash flow	¥505m	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in investing activities IFRS
Investing cash flow	¥3.6bn	2021-01-01 → 2021-12-31^d	Cons.	Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow	¥340m	2020-01-01 → 2020-12-31^d	Cons.	Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow	¥4.6bn	2019-01-01 → 2019-12-31^d	Cons.	Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow	¥97m	2023-01-01 → 2023-12-31	Cons.	Net cash provided by used in financing activities IFRS
Financing cash flow	¥1.4bn	2022-01-01 → 2022-12-31	Cons.	Net cash provided by used in financing activities IFRS
Financing cash flow	¥171m	2021-01-01 → 2021-12-31^d	Cons.	Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow	¥454m	2020-01-01 → 2020-12-31^d	Cons.	Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow	¥463m	2019-01-01 → 2019-12-31^d	Cons.	Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)	¥-26.79	2023-01-01 → 2023-12-31	Cons.	Basic earnings loss per share IFRS
EPS (basic)	¥-40.92	2022-01-01 → 2022-12-31	Cons.	Basic earnings loss per share IFRS
EPS (basic)	¥-57.46	2021-01-01 → 2021-12-31^d	Cons.	Basic earnings loss per share IFRS (5-year summary)
EPS (basic)	¥-56.9	2020-01-01 → 2020-12-31^d	Cons.	Basic earnings loss per share IFRS (5-year summary)
EPS (basic)	¥-73.06	2019-01-01 → 2019-12-31^d	Cons.	Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)	¥-26.79	2023-01-01 → 2023-12-31	Cons.	Diluted earnings loss per share IFRS
EPS (diluted)	¥-40.92	2022-01-01 → 2022-12-31	Cons.	Diluted earnings loss per share IFRS
EPS (diluted)	¥-57.46	2021-01-01 → 2021-12-31^d	Cons.	Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)	¥-56.9	2020-01-01 → 2020-12-31^d	Cons.	Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)	¥-73.06	2019-01-01 → 2019-12-31^d	Cons.	Diluted earnings loss per share IFRS (5-year summary)
Net assets per share	¥47.21	at 2023-12-31	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥72.31	at 2022-12-31	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥90.55	at 2021-12-31^d	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥134.5	at 2020-12-31^d	Cons.	Equity to asset ratio IFRS (5-year summary)
Net assets per share	¥190.93	at 2019-12-31^d	Cons.	Equity to asset ratio IFRS (5-year summary)
Equity ratio	87.7%	at 2023-12-31	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	89.4%	at 2022-12-31	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	85.9%	at 2021-12-31^d	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	89.6%	at 2020-12-31^d	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio	92.4%	at 2019-12-31^d	Cons.	Ratio of owners equity to gross assets IFRS (5-year summary)
ROE	-45.2%	2023-01-01 → 2023-12-31	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	-49.8%	2022-01-01 → 2022-12-31	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	-51.6%	2021-01-01 → 2021-12-31^d	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	-34.6%	2020-01-01 → 2020-12-31^d	Cons.	Rate of return on equity IFRS (5-year summary)
ROE	-32.9%	2019-01-01 → 2019-12-31^d	Cons.	Rate of return on equity IFRS (5-year summary)
Employees	12	at 2023-12-31	Cons.	Number of employees
Employees	7	at 2022-12-31	Cons.	Number of employees
Employees	8	at 2021-12-31^d	Cons.	Number of employees
Employees	8	at 2020-12-31^d	Cons.	Number of employees
Employees	12	at 2019-12-31^d	Cons.	Number of employees
Revenue	¥214m	2023-01-01 → 2023-12-31	Standalone	Operating revenue1
Revenue	¥175m	2022-01-01 → 2022-12-31	Standalone	Operating revenue1
Revenue	¥173m	2021-01-01 → 2021-12-31^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥196m	2020-01-01 → 2020-12-31^d	Standalone	Operating revenue1 (5-year summary)
Revenue	¥254m	2019-01-01 → 2019-12-31^d	Standalone	Operating revenue1 (5-year summary)
Operating income	−¥146m	2023-01-01 → 2023-12-31	Standalone	Operating income
Operating income	−¥60m	2022-01-01 → 2022-12-31	Standalone	Operating income
Ordinary income	−¥733m	2023-01-01 → 2023-12-31	Standalone	Ordinary income
Ordinary income	−¥42m	2022-01-01 → 2022-12-31	Standalone	Ordinary income
Ordinary income	−¥96m	2021-01-01 → 2021-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	−¥107m	2020-01-01 → 2020-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	−¥166m	2019-01-01 → 2019-12-31^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	−¥725m	2023-01-01 → 2023-12-31	Standalone	Income before income taxes
Profit before tax	¥1m	2022-01-01 → 2022-12-31	Standalone	Income before income taxes
Net income	−¥726m	2023-01-01 → 2023-12-31	Standalone	Profit loss
Net income	¥530,000	2022-01-01 → 2022-12-31	Standalone	Profit loss
Net income	−¥54m	2021-01-01 → 2021-12-31^d	Standalone	Net income loss (5-year summary)
Net income	−¥96m	2020-01-01 → 2020-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥95m	2019-01-01 → 2019-12-31^d	Standalone	Net income loss (5-year summary)
Total assets	¥2.9bn	at 2023-12-31	Standalone	Assets
Total assets	¥3.5bn	at 2022-12-31	Standalone	Assets
Total assets	¥2.0bn	at 2021-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥1.7bn	at 2020-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥1.2bn	at 2019-12-31^d	Standalone	Total assets (5-year summary)
Total liabilities	¥59m	at 2023-12-31	Standalone	Liabilities
Total liabilities	¥47m	at 2022-12-31	Standalone	Liabilities
Net assets / equity	¥2.9bn	at 2023-12-31	Standalone	Net assets
Net assets / equity	¥3.4bn	at 2022-12-31	Standalone	Net assets
Net assets / equity	¥2.0bn	at 2021-12-31^d	Standalone	Net assets
Net assets / equity	¥1.7bn	at 2020-12-31^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥1.2bn	at 2019-12-31^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥2.5bn	at 2023-12-31	Standalone	Cash and deposits
Cash and deposits	¥3.3bn	at 2022-12-31	Standalone	Cash and deposits
EPS (basic)	¥-13.06	2023-01-01 → 2023-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥0.01	2022-01-01 → 2022-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-1.18	2021-01-01 → 2021-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥-2.23	2020-01-01 → 2020-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥2.26	2019-01-01 → 2019-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (diluted)	¥0.01	2022-01-01 → 2022-12-31	Standalone	Diluted earnings per share (5-year summary)
EPS (diluted)	¥2.26	2019-01-01 → 2019-12-31^d	Standalone	Diluted earnings per share (5-year summary)
Net assets per share	¥39.94	at 2023-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥51.56	at 2022-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥28.35	at 2021-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥23.19	at 2020-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥12.22	at 2019-12-31^d	Standalone	Net assets per share (5-year summary)
Equity ratio	76.6%	at 2023-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	80.8%	at 2022-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	65.3%	at 2021-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	59.5%	at 2020-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	43.1%	at 2019-12-31^d	Standalone	Equity to asset ratio (5-year summary)
ROE	0.0%	2022-01-01 → 2022-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	86.9%	2019-01-01 → 2019-12-31^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	56,062,988	at 2023-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	54,622,588	at 2022-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	45,861,688	at 2021-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	44,558,588	at 2020-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	42,303,188	at 2019-12-31^d	Standalone	Total number of issued shares (5-year summary)
Employees	9	at 2023-12-31	Standalone	Number of employees
Employees	5	at 2022-12-31	Standalone	Number of employees
Employees	2	at 2021-12-31^d	Standalone	Number of employees
Employees	2	at 2020-12-31^d	Standalone	Number of employees
Employees	3	at 2019-12-31^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

All source rows · 1,057

Item	Context	Value	Unit
Total changes of items during the period	CurrentYearDuration_NonConsolidatedMember_TreasuryStockMember	-0	JPY
Total changes of items during the period	CurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember	-577217000	JPY
Total changes of items during the period	CurrentYearDuration_NonConsolidatedMember_SubscriptionRightsToSharesMember	4664000	JPY
Total changes of items during the period	CurrentYearDuration_NonConsolidatedMember	-572553000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember_CapitalStockMember	2141112000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember_LegalCapitalSurplusMember	2140612000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember	-2042358000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember_TreasuryStockMember	-65000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember	2239301000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember	627174000	JPY
Net assets	CurrentYearInstant_NonConsolidatedMember	2866475000	JPY
Directors compensations sga	Prior1YearDuration_NonConsolidatedMember	32021000	JPY
Directors compensations sga	CurrentYearDuration_NonConsolidatedMember	65922000	JPY
Provision for directors bonuses sga	Prior1YearDuration_NonConsolidatedMember	2195000	JPY
Provision for directors bonuses sga	CurrentYearDuration_NonConsolidatedMember	16866000	JPY
Payroll and allowances sga	Prior1YearDuration_NonConsolidatedMember	29240000	JPY
Payroll and allowances sga	CurrentYearDuration_NonConsolidatedMember	44174000	JPY
Commission fee sga	Prior1YearDuration_NonConsolidatedMember	81257000	JPY
Commission fee sga	CurrentYearDuration_NonConsolidatedMember	118399000	JPY
Depreciation sga	Prior1YearDuration_NonConsolidatedMember	1126000	JPY
Depreciation sga	CurrentYearDuration_NonConsolidatedMember	4350000	JPY
Document title cover page	FilingDateInstant	Original text (Japanese) 有価証券報告書
Clause of stipulation cover page	FilingDateInstant	Original text (Japanese) 金融商品取引法第24条第１項
Place of filing cover page	FilingDateInstant	Original text (Japanese) 関東財務局長
Filing date cover page	FilingDateInstant	2024-03-29
Fiscal year cover page	FilingDateInstant	Original text (Japanese) 第９期（自　2023年１月１日　至　2023年12月31日）
Company name cover page	FilingDateInstant	Original text (Japanese) 窪田製薬ホールディングス株式会社
Company name in english cover page	FilingDateInstant	Kubota Pharmaceutical Holdings Co., Ltd.
Title and name of representative cover page	FilingDateInstant	Original text (Japanese) 代表取締役会長、社長兼最高経営責任者　　窪田　良
Address of registered headquarter cover page	FilingDateInstant	Original text (Japanese) 東京都港区南青山一丁目15番37号
Telephone number address of registered headquarter cover page	FilingDateInstant	03-6550-8928
Name of contact person address of registered headquarter cover page	FilingDateInstant	Original text (Japanese) 取締役、最高事業責任者　　市川　今代
Nearest place of contact cover page	FilingDateInstant	Original text (Japanese) 東京都港区南青山一丁目15番37号
Telephone number nearest place of contact cover page	FilingDateInstant	03-6550-8928
Name of contact person nearest place of contact cover page	FilingDateInstant	Original text (Japanese) 取締役、最高事業責任者　　市川　今代
Place for public inspection cover page (text)	FilingDateInstant	Text · Plus
Edinet code	FilingDateInstant	E32854
Fund code	FilingDateInstant	－
Security code	FilingDateInstant	45960
Filer name in japanese	FilingDateInstant	Original text (Japanese) 窪田製薬ホールディングス株式会社
Filer name in english	FilingDateInstant	Kubota Pharmaceutical Holdings Co., Ltd.
Fund name in japanese	FilingDateInstant	－
Fund name in english	FilingDateInstant	－
Cabinet office ordinance	FilingDateInstant	Original text (Japanese) 企業内容等の開示に関する内閣府令
Document type	FilingDateInstant	Original text (Japanese) 第三号様式
Accounting standards	FilingDateInstant	IFRS
Whether consolidated financial statements are prepared	FilingDateInstant	true
Industry code when consolidated financial statements are prepared in accordance with industry specific regulations	FilingDateInstant	CTE
Industry code when financial statements are prepared in accordance with industry specific regulations	FilingDateInstant	CTE
Current fiscal year start date	FilingDateInstant	2023-01-01

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 18 of 19 passed

balance sheet identity	consolidated 2022-12-31	pass
balance sheet identity	consolidated 2023-12-31	pass
balance sheet identity	non_consolidated 2022-12-31	pass
balance sheet identity	non_consolidated 2023-12-31	pass rounding
dei present		pass
period resolution		partial
statement vs summary · net assets	non_consolidated 2021-12-31	pass
statement vs summary · net assets	non_consolidated 2022-12-31	pass
statement vs summary · net assets	non_consolidated 2023-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2023-01-01/2023-12-31	pass
statement vs summary · operating cash flow	consolidated 2022-01-01/2022-12-31	pass
statement vs summary · operating cash flow	consolidated 2023-01-01/2023-12-31	pass
statement vs summary · revenue	non_consolidated 2022-01-01/2022-12-31	pass
statement vs summary · revenue	non_consolidated 2023-01-01/2023-12-31	pass
statement vs summary · total assets	consolidated 2022-12-31	pass
statement vs summary · total assets	consolidated 2023-12-31	pass
statement vs summary · total assets	non_consolidated 2022-12-31	pass
statement vs summary · total assets	non_consolidated 2023-12-31	pass